Package 68001-614-04
Brand: bupropion hydrochloride
Generic: bupropion hydrochloridePackage Facts
Identity
Package NDC
68001-614-04
Digits Only
6800161404
Product NDC
68001-614
Description
30 TABLET in 1 BOTTLE (68001-614-04)
Marketing
Marketing Status
Brand
bupropion hydrochloride
Generic
bupropion hydrochloride
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "48e4e5a0-3a1f-3aa1-e063-6394a90ad05f", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["4956af38-182a-4015-a945-67e40bd38772"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE (68001-614-03)", "package_ndc": "68001-614-03", "marketing_start_date": "20240409"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (68001-614-04)", "package_ndc": "68001-614-04", "marketing_start_date": "20240620"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (68001-614-05)", "package_ndc": "68001-614-05", "marketing_start_date": "20240620"}], "brand_name": "Bupropion hydrochloride", "product_id": "68001-614_48e4e5a0-3a1f-3aa1-e063-6394a90ad05f", "dosage_form": "TABLET", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "68001-614", "generic_name": "Bupropion hydrochloride", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA215568", "marketing_category": "ANDA", "marketing_start_date": "20240409", "listing_expiration_date": "20271231"}